INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780VAB8. A total of 9 filers reported holding INOTEK PHARMACEUTICALS CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,706,000 | +9.6% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,469,000 | -1.0% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $2,493,000 | -56.3% | 2,500,000 | -56.5% | 0.00% | -60.0% |
| Q1 2019 | $5,703,000 | +5.0% | 5,750,000 | 0.0% | 0.01% | -16.7% |
| Q4 2018 | $5,433,000 | +3.7% | 5,750,000 | +21.1% | 0.01% | +20.0% |
| Q3 2018 | $5,239,000 | +160.0% | 4,750,000 | +137.5% | 0.01% | +150.0% |
| Q2 2018 | $2,015,000 | +5.3% | 2,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,914,000 | – | 2,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 7,700,000 | $6,036,000 | 0.92% |
| Telemetry Investments, L.L.C. | 1,750,000 | $1,403,000 | 0.54% |
| Springhouse Capital Management, LP | 1,300,000 | $988,000 | 0.48% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 8,750,000 | $7,016,000 | 0.45% |
| Bruce & Co., Inc. | 2,000,000 | $1,600,000 | 0.35% |
| DAFNA Capital Management LLC | 600,000 | $452,000 | 0.24% |
| Orbimed Advisors | 7,000,000 | $5,918,000 | 0.08% |
| Baker Brothers Advisors | 5,000,000 | $4,009,000 | 0.04% |
| Citadel Advisors | 7,500,000 | $5,700,000 | 0.00% |